BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31584500)

  • 1. Open Mastoid Cavity Obliteration With a High-Porosity Hydroxyapatite Ceramic Leads to High Rate of Revision Surgery and Insufficient Cavity Obliteration.
    Weiss NM; Stecher S; Bächinger D; Schuldt T; Langner S; Zonnur S; Mlynski R; Schraven SP
    Otol Neurotol; 2020 Jan; 41(1):e55-e63. PubMed ID: 31584500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mastoid cavity obliteration leads to a clinically significant improvement in health-related quality of life.
    Weiss NM; Bächinger D; Botzen J; Großmann W; Mlynski R
    Eur Arch Otorhinolaryngol; 2020 Jun; 277(6):1637-1643. PubMed ID: 32144569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mastoid cavity obliteration with allogenic and autologous material].
    Weiss N; Stallbaum T; Botzen J; Bächinger D; Großmann W; Bernd HE; Mlynski R
    Laryngorhinootologie; 2022 Jan; 101(1):40-44. PubMed ID: 33946124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of chronic middle ear disease. III. Revisions after tympanomastoid surgery.
    Palva T
    Acta Otolaryngol; 1988; 105(1-2):82-9. PubMed ID: 3341165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary experience with beta-tricalcium phosphate for use in mastoid cavity obliteration after mastoidectomy.
    Minoda R; Hayashida M; Masuda M; Yumoto E
    Otol Neurotol; 2007 Dec; 28(8):1018-21. PubMed ID: 17898672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A technique for concurrent procedure of mastoid obliteration and meatoplasty after canal wall down mastoidectomy.
    Kim CW; Oh JI; Choi KY; Park SM; Park MI
    Auris Nasus Larynx; 2012 Dec; 39(6):557-61. PubMed ID: 22321811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tympanoplasty with mastoid obliteration using hydroxyapatite granules for aural cholesteatoma--a clinical and experimental study].
    Takahashi S
    Nihon Jibiinkoka Gakkai Kaiho; 1991 Jun; 94(6):833-42. PubMed ID: 1653315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful obliteration of troublesome and chronically draining cavities.
    Geerse S; Ebbens FA; de Wolf MJ; van Spronsen E
    J Laryngol Otol; 2017 Feb; 131(2):138-143. PubMed ID: 28069077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastoid and epitympanic bony obliteration in pediatric cholesteatoma.
    Vercruysse JP; De Foer B; Somers T; Casselman JW; Offeciers E
    Otol Neurotol; 2008 Oct; 29(7):953-60. PubMed ID: 18719515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total mastoid obliteration in staged canal-up tympanoplasty for cholesteatoma facilitates tympanic aeration.
    Yanagihara N; Komori M; Hinohira Y
    Otol Neurotol; 2009 Sep; 30(6):766-70. PubMed ID: 19704361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing and hearing rehabilitation after obliteration of troublesome mastoid cavities.
    Geerse S; Bost TJM; Allagul S; de Wolf MJF; Ebbens FA; van Spronsen E
    Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3307-3313. PubMed ID: 32444965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of demineralized bone matrix for mastoid cavity obliteration.
    Leatherman BD; Dornhoffer JL
    Otol Neurotol; 2004 Jan; 25(1):22-5; discussion 25-6. PubMed ID: 14724487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mastoid and epitympanic obliteration in canal wall up mastoidectomy for prevention of retraction pocket.
    Lee WS; Choi JY; Song MH; Son EJ; Jung SH; Kim SH
    Otol Neurotol; 2005 Nov; 26(6):1107-11. PubMed ID: 16272924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type III tympanoplasty with titanium total ossicular replacement prosthesis: anatomic and functional results.
    Iñiguez-Cuadra R; Alobid I; Borés-Domenech A; Menéndez-Colino LM; Caballero-Borrego M; Bernal-Sprekelsen M
    Otol Neurotol; 2010 Apr; 31(3):409-14. PubMed ID: 20042992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mastoid obliteration with hydroxyapatite vs. bone pâté in mastoidectomy surgery performed on patients with cholesteatoma and chronic suppurative otitis media: a retrospective analysis.
    Lindeboom JJ; van Kempen PMW; Buwalda J; Westerlaken BO; van Zuijlen DA; Bom SJH; van der Beek FB
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1703-1711. PubMed ID: 36173443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obliteration of the middle ear cavity in children: the current state of the problem and our first experience].
    Rusetsky YY; Chernova OV; Meytel IY; Sotnikova LS; Farikov SE; Yakushenkova AP
    Vestn Otorinolaringol; 2021; 86(2):21-27. PubMed ID: 33929147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The hearing outcomes of modified canal wall down and canal wall up mastoidectomy and tympanoplasty].
    Wang Y; Pan T; Lu ZY; Ma FR
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Aug; 55(8):748-753. PubMed ID: 32791772
    [No Abstract]   [Full Text] [Related]  

  • 18. [Revisional radical mastoidectomy surgeries--25 cases'experience].
    Li L; Xie J; Liu Y; Gong SS
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Oct; 52(10):766-770. PubMed ID: 29050095
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgical Treatment for Troublesome Mastoid Cavities: Canal Wall Reconstruction With Bony Obliteration Versus Subtotal Petrosectomy.
    Kemps G; Geven L; Kunst H; Mylanus E; Mulder J; Lanting C; Pennings R
    Otol Neurotol; 2024 Mar; 45(3):273-280. PubMed ID: 38270225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial mastoid obliteration combined with soft-wall reconstruction for middle ear cholesteatoma.
    Suzuki H; Ikezaki S; Imazato K; Koizumi H; Ohbuchi T; Hohchi N; Hashida K
    Ann Otol Rhinol Laryngol; 2014 Aug; 123(8):571-5. PubMed ID: 24634153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.